Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suhrke

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
ESMO Open|June 5, 2024
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)H O Ohnstad, E S Blix, L A Akslen, et al.
Journal of Translational Medicine|May 15, 2022
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Journal of Translational Medicine|July 15, 2022
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
ESMO Open|June 5, 2024
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)H O Ohnstad, E S Blix, L A Akslen, et al.
Journal of Translational Medicine|May 15, 2022
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Journal of Translational Medicine|July 15, 2022
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Pageof 4